Ansung Tech Closes ~CNY 150M Series C3 Round; Lingke Pharmaceutical’s Zepacitinib NDA Accepted by NMPA
May 29, 2026 09:00
CST Updated
11:55
Allink Biotherapeutics
Innovative Drug Developer
Lynk Pharmaceuticals
FIC/BIC Small Molecule Drug Developer